Chemical activators of OSTα include a variety of bile acids and synthetic compounds that can enhance the functional activity of this protein. Cholic acid and deoxycholic acid, both primary bile acids, can elevate the OSTα activity by increasing the levels of substrates available for transport, thereby directly stimulating the protein's transport function. Similarly, chenodeoxycholic acid serves as an endogenous ligand for the farnesoid X receptor (FXR) and upon binding, can induce a cellular response that includes the upregulation of bile acid transport mechanisms in which OSTα is integral. Ursodeoxycholic acid further supports OSTα activity by improving bile flow, which may increase the functional demand on OSTα for bile acid transport. Tauroursodeoxycholic acid's role in membrane stabilization can also enhance OSTα function by optimizing the membrane environment, facilitating more efficient transport activity.
Other bile acid conjugates such as glycochenodeoxycholic acid, taurocholic acid, glycocholic acid (GCA), and taurochenodeoxycholic acid (TCDCA) serve as direct substrates for OSTα, thereby activating the protein through increased substrate handling. This engagement with OSTα ensures that it remains functionally active as it works to transport these molecules across the cell membrane. Synthetic FXR agonists like GW4064 and obeticholic acid indirectly activate OSTα by modulating FXR, which in turn can lead to an upregulation of the entire bile acid transport system, including OSTα. This engagement signifies that OSTα activity can be enhanced through the broader regulatory network of bile acid homeostasis. Lastly, barbituric acid, although not a bile acid, can influence hepatic enzyme systems and thereby may have an indirect effect on OSTα by altering bile acid metabolism, which could necessitate a compensatory increase in the transport activities of OSTα. Each of these chemicals plays a role in ensuring the sustained and enhanced activity of OSTα through substrate availability, receptor-mediated pathway activation, or cellular transport demand.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cholic acid | 81-25-4 | sc-255020 sc-255020A sc-255020B sc-255020C sc-255020D | 25 g 100 g 500 g 1 kg 5 kg | $48.00 $121.00 $567.00 $998.00 $4480.00 | 11 | |
Cholic acid is a primary bile acid that can enhance the functional activity of OSTα by increasing the substrate availability, thus potentially upregulating the transport activity of OSTα in the liver and intestine. | ||||||
Deoxycholic acid | 83-44-3 | sc-214865 sc-214865A sc-214865B | 5 g 25 g 1 kg | $36.00 $66.00 $923.00 | 4 | |
Deoxycholic acid, being another primary bile acid, can similarly upregulate OSTα activity by acting as a substrate that needs to be transported, thereby increasing the demand for OSTα's transport function. | ||||||
Chenodeoxycholic acid, free acid | 474-25-9 | sc-278835 sc-278835A | 1 g 5 g | $27.00 $115.00 | ||
As a potent endogenous ligand for the farnesoid X receptor (FXR), chenodeoxycholic acid can indirectly enhance OSTα activity by binding to FXR, which may lead to a cellular response that includes the upregulation of bile acid transport mechanisms. | ||||||
Tauroursodeoxycholic Acid, Sodium Salt | 14605-22-2 | sc-281165 | 1 g | $644.00 | 5 | |
Tauroursodeoxycholic acid can protect and stabilize cell membranes, potentially enhancing OSTα activity by improving the membrane environment in which OSTα operates, thus indirectly increasing its functional activity. | ||||||
Glycocholic acid | 475-31-0 | sc-218574 sc-218574A sc-218574B sc-218574C sc-218574D sc-218574E | 100 mg 1 g 5 g 10 g 50 g 100 g | $72.00 $184.00 $637.00 $1234.00 $1642.00 $3070.00 | 4 | |
GCA, as a bile acid conjugate, would increase substrate levels for OSTα, potentially enhancing its transport activity as it actively transports such molecules across the cell membrane. | ||||||
GW 4064 | 278779-30-9 | sc-218577 | 5 mg | $93.00 | 13 | |
GW4064 is a synthetic FXR agonist that can indirectly activate OSTα by triggering FXR, which may lead to an upregulation of bile acid transport systems, including OSTα. | ||||||